Skip to main content
. 2015 Feb 7;14:69. doi: 10.1186/s12936-015-0576-8

Table 3.

Unadjusted model: SP a -IPTp b doses (categorical variables) associated with outcomes of interest

Unadjusted model IPTp <2 vs≥ 2 SP doses n, PR c (95% CI d ) IPTp <3 vs ≥3 SP doses n, PR (95% CI) IPTp 2 vs ≥3 SP doses n, PR (95% CI)
Placental infectione
All gravidity 435, 0.78 (0.61-0.99) 435, 0.80 (0.61-1.06) 286, 0.89 (0.64-1.23)
Paucigravid 218, 0.67 (0.51-0.88) 218, 0.80 (0.57-1.12) 147, 0.98 (0.66-1.47)
Multigravid 214, 0.93 (0.60-1.44) 214, 0.81 (0.50-1.30) 137, 0.79 (0.46-1.36)
Low birth weight (<2,500 g)
All gravidity 435, 0.41 (0.22-0.79) 435, 0.35 (0.14-0.88) 286, 0.49 (0.17-1.41)
Paucigravid 218, 0.27 (0.09-0.77) 218, 0.36 (0.08-1.56) 147, 0.75 (0.13-4.38)
Multigravid 214, 0.51 (0.21-1.19) 214, 0.23 (0.05-0.96) 137, 0.25 (0.05-1.16)
Preterm (<37 weeks)
All gravidity 429, 0.51 (0.32-0.81) 429, 0.40 (0.21-0.77) 281, 0.50 (0.24-1.02)
Paucigravid 216, 0.81 (0.43-1.51) 216, 0.64 (0.31-1.34) 146, 0.66 (0.29-1.47)
Multigravid 210, 0.26 (0.12-0.56) 210, 0.16 (0.04-0.67) 133, 0.29 (0.06-1.39)
Small for gestational age
All gravidity 428, 0.95 (0.62-1.45) 428, 0.83 (0.53-1.30) 281, 0.81 (0.48-1.35)
Paucigravid 216, 1.11 (0.62-1.99) 216, 0.94 (0.53-1.69) 146, 0.88 (0.46-1.67)
Multigravid 209, 0.79 (0.41-1.52) 209, 0.68 (0.32-1.43) 133, 0.70 (0.29-1.66)
Composite birth outcomef
All gravidity 435, 0.74 (0.56-0.98) 435, 0.64 (0.45-0.90) 286, 0.69 (0.47-1.01)
Paucigravid 218, 0.99 (0.67-1.45) 218, 0.82 (0.55-1.25) 147, 0.79 (0.50-1.25)
Multigravid 214, 0.50 (0.32-0.79) 214, 0.43 (0.23-0.80) 137, 0.55 (0.27-1.12)
Anemia (Hb <11 g/dl)
All gravidity 434, 0.89 (0.70-1.13) 434, 0.87 (0.67-1.13) 285, 0.90 (0.67-1.22)
Paucigravid 217, 0.75 (0.55-1.03) 217, 0.72 (0.49-1.06) 146, 0.79 (0.51-1.22)
Multigravid 214, 1.06 (0.74-1.53) 214, 1.08 (0.75-1.54) 137, 1.06 (0.69-1.62)
Any infectiong
All gravidity 435, 0.78 (0.61-0.99) 435, 0.79 (0.60-1.04) 286, 0.87 (0.64-1.20)
Paucigravid 218, 0.66 (0.50-0.86) 218, 0.80 (0.57-1.10) 147, 0.99 (0.67-1.46)
Multigravid 214, 0.95 (0.62-1.47) 214, 0.79 (0.49-1.26) 137, 0.75 (0.44-1.28)

aSP = sulphadoxine pyrimethamine.

bIPTp = intermittent preventive treatment for malaria in pregnancy.

cPR = prevalence ratio.

dDenotes 95% confidence interval.

ePlacental infection outcome: classes 1–4 vs class 5.

fComposite birth outcome defined as infants born with any of: LBW, SGA, or preterm.

gAny infection defined as: pathology classes 1–4, blood smear positive (maternal, placental or cord blood).